Eric. J. Simon

Eric. J. Simon's AcademicInfluence.com Rankings

Eric. J. Simon

Medical

#2046

World Rank

#2440

Historical Rank

Pharmacology

#209

World Rank

#249

Historical Rank

medical Degrees

Download Badge

Medical

Eric. J. Simon's Degrees

PhD Pharmacology University of California, San Francisco
Bachelors Biology University of California, San Diego

Similar Degrees You Can Earn

Best Online Bachelor's in Biology 2025

Why Is Eric. J. Simon Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Eric. J. Simon's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Stereospecific binding of the potent narcotic analgesic (3H) Etorphine to rat-brain homogenate. (1973) (1047)
The Preparation of S-Succinyl Coenzyme A (1953) (763)
Structural model for the β-amyloid fibril based on interstrand alignment of an antiparallel-sheet comprising a C-terminal peptide (1995) (398)
Evidence from opiate binding studies that heroin acts through its metabolites. (1983) (198)
Ontological development of opiate receptors in rodent brain (1976) (190)
Further properties of stereospecific opiate binding sites in rat brain: on the nature of the sodium effect. (1975) (179)
Distribution of stereospecific binding of the potent narcotic analgesic etorphine in the human brain: predominance in the limbic system. (1973) (176)
Multiple opiate receptors: alcohol selectively inhibits binding to delta receptors. (1981) (141)
Kinetics of opiate receptor inactivation by sulfhydryl reagents: evidence for conformational change in presence of sodium ions. (1975) (139)
Receptor affinity and pharmacological potency of a series of narcotic analgesic, anti-diarrheal and neuroleptic drugs. (1977) (128)
Selective protection of stereospecific enkephalin and opiate binding against inactivation by N-ethylmaleimide: evidence for two classes of opiate receptors. (1980) (113)
Interaction between the mu opioid receptor and filamin A is involved in receptor regulation and trafficking. (2003) (111)
Opiate receptors in cultures of fetal mouse dorsal root ganglia (DRG) and spinal cord: predominance in DRG neurites (1978) (111)
μ-, δ- and κ-opioid receptor populations are differentially altered in distinct areas of postmortem brains of Alzheimer’s disease patients (2001) (97)
Purification of an active opioid-binding protein from bovine striatum. (1985) (94)
Opioid receptors and endogenous opioid peptides (1991) (94)
Covalent labeling of opioid receptors with radioiodinated human beta-endorphin. Identification of binding site subunit. (1985) (85)
Selective changes in μ, δ and ϰ opioid receptor binding in certain limbic regions of the brain in Alzheimer's disease patients (1987) (81)
An impaired concentrating mechanism for amino acids in mutants of Escherichia coli resistant to L-canavanine and D-serine. (1959) (74)
Solubilization of a stereospecific opiate-macromolecular complex from rat brain (1975) (74)
Cross-linking of human [125I]beta-endorphin to opioid receptors in rat striatal membranes: biochemical evidence for the existence of a mu/delta opioid receptor complex. (1990) (66)
Lectin binding of solubilized opiate receptors: evidence for their glycoprotein nature. (1982) (66)
μ and δ-opioid receptor agonists induce mitogen-activated protein kinase (MAPK) activation in the absence of receptor internalization (2000) (66)
Turnover of muscle and liver proteins in mice with hereditary muscular dystrophy. (1962) (65)
Potentiation of reward by hunger is opioid mediated (1984) (61)
Initiation of chains by RNA polymerase and the effects of inhibitors studied by a direct filtration technique. (1968) (61)
Role of Protein Kinase C (PKC) in Agonist‐Induced α‐Opioid Receptor Down‐Regulation (1999) (60)
Specific, high affinity [3H]ethylketocyclazocine binding in rat central nervous system: lack of evidence for kappa receptors. (1980) (60)
Solubilization and characterization of active opiate binding sites from mammalian brain. (1982) (59)
Solubilization of an active opiate receptor from Bufo marinus. (1980) (59)
In vitro studies on opiate receptors and their ligands. (1978) (59)
The opiate receptors (1976) (58)
Phospholipase A inhibition of opiate receptor binding can be reversed by albumin (1978) (55)
Effects of naloxone and its quarternary analogue on stimulation-induced feeding (1983) (55)
Characterization and partial purification of solubilized active opiate receptors from toad brain. (1981) (55)
METABOLISM OF POLYAMINES IN MOUSE NEUROBLASTOMA CELLS IN CULTURE: 1 FORMATION OF GABA AND PUTREANINE (1975) (53)
Role of protein kinase C (PKC) in agonist-induced mu-opioid receptor down-regulation: I. PKC translocation to the membrane of SH-SY5Y neuroblastoma cells is induced by mu-opioid agonists. (1999) (50)
Characterization of specific binding sites for [3H](d)-N-allylnormetazocine in rat brain membranes. (1985) (50)
The nature of opiate receptors in toad brain. (1982) (49)
Tyrosine phosphorylation of the delta-opioid receptor. Evidence for its role in mitogen-activated protein kinase activation and receptor internalization*. (2000) (48)
Effects of chronic food restriction on mu and kappa opioid binding in rat forebrain: a quantitative autoradiographic study (1994) (47)
Effects of stress on opioid receptor binding in the rat central nervous system (1992) (46)
Opiate binding sites in the retina: properties and distribution. (1980) (46)
Selective depression by opioid peptides of sensory-evoked dorsal-horn network responses in organized spinal cord cultures (1978) (45)
INHIBITION OF RNA SYNTHESIS IN ESCHERICHIA COLI BY LEVORPHANOL. (1964) (44)
Mu-, delta- and kappa-opioid receptor populations are differentially altered in distinct areas of postmortem brains of Alzheimer's disease patients. (2001) (42)
Delta Opioid activation of the Mitogen-activated protein kinase cascade does not require transphosphorylation of Receptor Tyrosine Kinases (2002) (42)
Effects of parabrachial opioid antagonism on stimulation-induced feeding (1991) (41)
Effects of levorphanol on phospholipid metabolism and composition in Escherichia coli. (1971) (41)
Selective opiate depression of sensory-evoked synaptic networks in dorsal horn regions of spinal cord cultures (1977) (41)
Solubilization and characterization of mu, delta, and kappa opioid binding sites from guinea pig brain: physical separation of kappa receptors. (1984) (39)
Chronic food restriction alters μ and κ opioid receptor binding in the parabrachial nucleus of the rat: a quantitative autoradiographic study (1996) (38)
Mutation of tyrosine 318 (Y318F) in the delta-opioid receptor attenuates tyrosine phosphorylation, agonist-dependent receptor internalization, and mitogen-activated protein kinase activation. (2000) (37)
Immunohistochemical localization of Mu-opioid receptors in rat brain using antibodies generated against a peptide sequence present in a purified mu-opioid binding protein (1994) (37)
3H-ethylketocyclazocine binding: Lack of evidence for a separate κ receptor in rats CNS (1979) (36)
mu and delta-opioid receptor agonists induce mitogen-activated protein kinase (MAPK) activation in the absence of receptor internalization. (2000) (36)
Role of protein kinase C (PKC) in agonist-induced mu-opioid receptor down-regulation: II. Activation and involvement of the alpha, epsilon, and zeta isoforms of PKC. (1999) (34)
Development of tolerance to opiates and opioid peptides in organotypic cultures of mouse spinal cord. (1979) (34)
Characterization of Solubilized Opioid Receptors: Reconstitution and Uncoupling of Guanine Nucleotide‐Sensitive Agonist Binding (1992) (34)
Effects of stress and beta-funal trexamine pretreatment on morphine analgesia and opioid binding in rats. (1987) (34)
Antagonist-induced opiate receptor upregulation in cultures of fetal mouse spinal cord-ganglion explants. (1986) (33)
Opiate receptor heterogeneity in human brain regions (1981) (33)
Localization of promoter elements in the human mu-opioid receptor gene and regulation by DNA methylation. (1999) (33)
Recent Studies on Opioid Receptors: Heterogeneity and Purification (1986) (33)
Identification of distinct binding site subunits of mu and delta opioid receptors. (1986) (32)
Opiate receptors and their interactions with agnoists and antagonists. (1975) (32)
Coupling of a new, active morphine derivative to sepharose for affinity chromatography. (1972) (31)
Antibodies to dynorphin A(1–13) but not β-endorphin inhibit electrically elicited feeding in the rat (1987) (31)
The effects of the morphine analogue levorphanol on leukocytes. Metabolic effects at rest and during phagocytosis. (1971) (30)
Characterization of the selective inhibition of the delta subclass of opioid binding sites by alcohols. (1984) (29)
Effects of the selective kappa opioid antagonist, nor-binaltorphimine, on electrically-elicited feeding in the rat. (1989) (29)
Potential affinity labels for the opiate receptor based on fentanyl and related compounds. (1982) (28)
In search of the opiate receptor. (1973) (28)
Inhibition of Bacterial Growth by Drugs of the Morphine Series (1964) (28)
Studies on the Intracellular Distribution and Tissue Binding of Dihydromorphine-7,8-H3 in the Rat∗ (1966) (27)
Opioid Receptor Multiplicity: Isolation, Purification, and Chemical Characterization of Binding Sites (1993) (27)
Benzodiazepine binding sites are present in retina. (1979) (27)
Identification of a neurorestrictive suppressor element (NRSE) in the human mu-opioid receptor gene. (2001) (25)
Lesioning of the nucleus basalis of Meynert has differential effects on mu, delta and kappa opioid receptor binding in rat brain: a quantitative autoradiographic study (1992) (24)
SELECTIVE INHIBITION OF SYNTHESIS OF RIBOSOMAL RNA IN ESCHERICHIA COLI BY LEVORPHANOL. (1964) (22)
Synthesis and evaluation of fluorinated derivatives of fentanyl as candidates for opiate receptor studies using positron emission tomograpry (1986) (22)
Autoradiographic comparison of [3H]DPDPE and [3H]DSLET binding: evidence for distinct δ1 and δ2 opioid receptor populations in rat brain (1996) (21)
Polyamines and inhibition of RNA synthesis in E. coli by levorphanol. (1966) (21)
Multiple opiate binding sites in human brain regions: Evidence for κ and σ sites (1982) (21)
Inhibition of Synthesis of RNA in E. coli by the Narcotic Drug Lævorphanol (1963) (20)
Quaternary derivatives of narcotic antagonists: stereochemical requirements at the chiral nitrogen for in vitro and in vivo activity. (1983) (20)
Subunit structure and purification of opioid receptors. (1987) (19)
The bovine mu-opioid receptor: cloning of cDNA and pharmacological characterization of the receptor expressed in mammalian cells. (1999) (19)
Affinity chromatography of solubilized opioid binding sites using CH-Sepharose modified with a new naltrexone derivative. (1984) (18)
Sodium ions increase the binding of the antagonist peptide ICI 174864 to the δ-opiate receptor (1986) (18)
In vitro effect of tocopherol metabolites on respiratory decline in dietary necrotic liver degeneration. (1959) (18)
Part IX. Opiate Receptors and the Behavioral Implications of Endorphins: OPIATE RECEPTORS AND OPIOID PEPTIDES: AN OVERVIEW (1982) (18)
Selective changes in mu, delta and kappa opioid receptor binding in certain limbic regions of the brain in Alzheimer's disease patients. (1987) (18)
Filamin A Mutant Lacking Actin-Binding Domain Restores Mu Opioid Receptor Regulation in Melanoma Cells (2008) (17)
Evidence for the presence of disulfide bridges in opioid receptors essential for ligand binding. Possible role in receptor activation (1989) (17)
Effect of levorphanol on putrescine transport in Escherichia coli. (1970) (16)
Characterization of phospholipase A inhibition of stereospecific opiate binding and its reversal by bovine serum albumin. (1981) (16)
Inactivation and solubilization of opiate receptors by phospholipases A2. (1982) (15)
Functional significance of cysteine residues in the delta opioid receptor studied by site-directed mutagenesis. (1998) (15)
The role of opioids in feeding and reward elicited by lateral hypothalamic electrical stimulation. (1983) (15)
Benzodiazepine binding in chicken retina and its interaction with γ-aminobutyric acid (1980) (15)
Antisera against peptides derived from a purified mu-opioid binding protein recognize the protein as well as mu-opioid receptors in brain regions and a cell line. (1993) (15)
Mu and kappa opioid agonists elevate brain stimulation threshold for escape by inhibiting aversion (1982) (15)
Computer automated structure evaluation of opiate alkaloids (1986) (15)
Solubilization in good yield of active opiate binding sites from mammalian brain. (1982) (15)
The effect of the morphine analog levorphanol on phagocytosing leukocytes. A morphologic study. (1971) (15)
Opiate receptors: some recent developments (1981) (15)
Chronic food restriction alters mu and kappa opioid receptor binding in the parabrachial nucleus of the rat: a quantitative autoradiographic study. (1996) (14)
Brain stimulation-induced feeding alters regional opioid receptor binding in the rat: an in vivo autoradiographic study (1990) (14)
Inhibition of the synthesis of 5-S ribosomal RNA in Escherichia coli by levallorphan. (1969) (14)
Interaction with lectin of kappa opioid binding sites solubilized from human placenta. (1987) (14)
A member of the heat shock protein 40 family, hlj1, binds to the carboxyl tail of the human mu opioid receptor (2006) (13)
The Interaction Between the Mu Opioid Receptor and Filamin A (2010) (13)
Sulfhydryl groups on opioid receptors revisited. Evidence for two sulfhydryl groups at or near the active site of the mu opioid receptor. (1992) (13)
Activation of fos in mouse amygdala by local infusion of norepinephrine or atipamezole (1997) (12)
The Opiate Receptors (1988) (12)
Stereospecific Binding of the Potent Narcotic Analgesic [ 31 H ] Etorphine to Rat-Brain Homogenate ( opiate receptor / morphine / antagonist ) (12)
Functional Reconstitution of a Highly Purified μ‐Opioid Receptor Protein with Purified G Proteins in Liposomes (1995) (12)
Diphenhydramine potentiates narcotic but not endogenous opioid analgesia (1985) (12)
Interaction of ribonucleic acid polymerase from Escherichia coli with deoxyribonucleic acid. Inhibition of ribonucleic acid synthesis by interaction of luteoskyrin with the transcription complex. (1973) (12)
Chronic morphine treatment up-regulates mu opioid receptor binding in cells lacking filamin A (2007) (11)
Effect of digitonin on the binding of opiate agonists and antagonists to membrane-bound and soluble opioid binding sites (1984) (11)
Lumbar subarachnoid ethylenediaminetetraacetate induces hindlimb tetanic contractions in rats: prevention by CaCl2 pretreatment; observation of spinal nerve root degeneration. (1992) (11)
Development of Met-enkephalin immunoreactivity in organotypic explants of fetal mouse spinal cord and attached dorsal root ganglia. (1984) (11)
Reconstitution of a purified μ-opioid binding protein in liposomes : selective, high affinity, GTPγS-sensitive μ-opioid agonist binding is restored (1993) (10)
Electrophilic alpha-methylene-gamma-lactone and isothiocyanate opioid ligands related to etorphine. (1990) (10)
Recent studies on interaction between opioid peptides and their receptors. (1980) (10)
Age-related changes in kappa opioid receptors in the guinea-pig brain: A quantitative autoradiographic study (1992) (10)
Sodium ions increase the binding of the antagonist peptide ICI 174864 to the delta-opiate receptor. (1986) (10)
Diastereomeric 6-desoxy-6-spiro-alpha-methylene-gamma-butyrolactone derivatives of naltrexone and oxymorphone. Selective irreversible inhibition of naltrexone binding in an opioid receptor preparation by a conformationally restricted michael acceptor ligand. (1984) (10)
Affinity crosslinking of 125I-labeled human ß-endorphin to cell lines possessing either μ- or δ-type opioid binding sites (1988) (9)
Solubilization and characterization of kappa opioid binding sites from guinea pig cerebellum (1984) (9)
Effect of the position of the phenolic group in morphinans on their affinity for opiate receptor binding. (1981) (9)
Exposure to 4-aminopyridine prevents depressant effects of opiates on sensory-evoked dorsal-horn network responses in spinal cord cultures. (1982) (9)
Are the preservatives sodium bisulfite and ethylene diaminetetraacetate free from neurotoxic involvement? (1992) (8)
Distribution of 3H-morphine following lumbar subarachnoid injection in unanesthetized rabbits. (1989) (8)
Reversible inhibition of RNA phage replication and macromolecular synthesis by levorphanol. (1970) (8)
Presence of leucine-enkephalin in organotypic explants of fetal mouse spinal cord (1981) (8)
Endorphins, opiate receptors and their evolving biology. (1981) (8)
Analgesic effects of ethylketocyclazocine and morphine in rat and toad. (1984) (8)
Opioid receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database (2019) (8)
Hybromet: a ligand for purifying opioid receptors. (1985) (8)
Opiate Receptors and Endorphins (1982) (8)
Autoradiographic comparison of [3H]DPDPE and [3H]DSLET binding: evidence for distinct delta 1 and delta 2 opioid receptor populations in rat brain. (1996) (7)
A novel phencyclidine analog interacts selectively with mu opioid receptors. (1984) (7)
Analgesia following Subarachnoid Sodium Ibuprofen in rats (1992) (7)
Opioid activity of synthetic and naturally occurring enkephalin peptides. (1979) (7)
Opiate receptors and opioid peptides: an overview. (1982) (7)
Cross-linking of human 125I-β-endorphin to a μ-θ opioid receptor complex in rat striatum (1989) (7)
Limbic regions of the brain of Alzheimer's disease patients show selective changes in mu, delta and kappa opioid receptor binding. (1986) (6)
Multiple Opioid Receptors (1991) (6)
Medial thalamic lesions reduce the aversion-gating action of lateral hypothalamic stimulation (1982) (6)
Tyrosine phosphorylation of the δ-opioid receptor (2000) (6)
Pharmacokinetics of [3H]-buprenorphine in the rat. (1989) (6)
Immunoblots with rhodopsin antisera suggest that a purified mu opioid binding protein has structural characteristics of a G-protein-coupled receptor. (1992) (6)
Relative affinities of the quaternary narcotic antagonist, N-methyl levallorphan (SR 58002), for different types of opioid receptors (1985) (5)
Opioid agonists and antagonists. 6-Desoxy-6-substituted lactone, epoxide, and glycidate ester derivatives of naltrexone and oxymorphone. (1985) (5)
Evidence for the solubilization of multiple opioid binding sites from mammalian brain. (1983) (5)
Solubilization and Purification of Opioid Binding Sites (1988) (5)
The effect of levorphanol tartrate on ribonucleic acid synthesis in normal and regenerating rat liver. (1972) (4)
The selective inhibition of ribosomal RNA synthesis in E. coli by 2,4-Dinitrophenol. (1966) (4)
The purification of antimorphine antibodies by affinity chromatography. (1977) (4)
In vitro studies of opiate receptors. (1979) (4)
Inhibition by levorphanol of the induction of acetylcholinesterase in a mouse neuroblastoma cell line 1,2 (1973) (4)
An opiate receptor-associated aminopeptidase that degrades enkephalins (1985) (4)
Etorphine pharmacokinetics in the rat: Experimental data and mathematical model (1984) (4)
Alterations in δ opioid receptor levels in discrete areas of the neocortex and in the globus pallidus of the aging guinea pig: a quantitative autoradiographic study (1993) (4)
Inactivation of the Purified Bovine μ Opioid Receptor by Sulfhydryl Reagents (2004) (3)
Role of Protein Kinase C (PKC) in Agonist‐Induced μ‐Opioid Receptor Down‐Regulation (1999) (3)
Effect of morphine analogues on chemotaxis in Escherichia coli. (1978) (3)
Opiate receptors in cultures of fetal mouse dorsal root ganglia (DRG) and spinal cord: predominance in DRG neurites J.M. Hiller, E.J. Simon, S.M. Crain and E. Peterson, Brain Res., 145 (1978) 396–400 (1979) (3)
Benzodiazepine binding in chicken retina and its interaction with gamma-aminobutyric acid. (1980) (3)
Reconstitution of a purified mu-opioid binding protein in liposomes: selective, high affinity, GTP gamma S-sensitive mu-opioid agonist binding is restored. (1993) (3)
Cross-linking of 125I-beta-endorphin to rat striatal mu- and delta-opioid receptors under physiological conditions: evidence for an opioid receptor complex. (1990) (3)
DISTRIBUTION OF 3H-MORPHINE FOLLOWING LUMBAR EPIDURAL ADMINISTRATION IN RABBITS (1987) (3)
Inhibition by Levorphanol and Related Drugs of Amino Acid Transport by Isolated Membrane Vesicles from Escherichia coli (1975) (3)
The direct demonstration of binding of mu, delta and kappa agonists to digitonin-solubilized opioid receptors from bovine striatum. (1986) (3)
Recent work on opiate receptors: heterogeneity and solubilization. (1982) (2)
Chimeric enkephalin-cystatins: opioid binding and structure-activity relationships of inhibitory domains. (1992) (2)
Cross-linking of human 125I-beta-endorphin to a mu-delta opioid receptor complex in rat striatum. (1989) (2)
Alterations in delta opioid receptor levels in discrete areas of the neocortex and in the globus pallidus of the aging guinea pig: a quantitative autoradiographic study. (1993) (2)
Stimulus induced feeding alters regional opiate receptor binding in the rat: an in vivo audioradiographic study. (1990) (2)
Conjugate addition ligands of opioid antagonists. Methacrylate esters and ethers of 6 alpha- and 6 beta-naltrexol. (1990) (2)
3H-ethylketocyclazocine binding: lack of evidence for a separate kappa receptor in rats CNS. (1979) (2)
Opioid ligands related to tifluadom (1989) (2)
Selective depression by opiates and opioid peptides of sensory evoked dorsal horn network responses in organized fetal mouse spinal cord cultures. (1979) (2)
Opiate receptors in the central nervous system. (1977) (2)
[80] Morphine and related drugs (1974) (2)
Photoaffinity ligands for the mu opioid receptor. (1993) (2)
Solubilization and characterization of ,u, 6, and K opioid binding sites from guinea pig brain: Physical separation of K receptors (2)
Original paperOpioid ligands related to tifluadomLigands opioïdes apparentés au tifluadom (1989) (2)
Opioid receptors in GtoPdb v.2021.3 (2021) (2)
Differential sensitivity of major types of opioid binding sites to U.V. irradiation (1984) (2)
Affinity crosslinking of 125I-labeled human beta-endorphin to cell lines possessing either mu- or delta-type opioid binding sites. (1988) (1)
DIFFERENTIAL DISTRIBUTION OF [3H]DPDPE AND [3H]DSLET BINDING IN RAT BRAIN: EVIDENCE FOR DELTA RECEPTOR HETEROGENEITY (1995) (1)
EPIDURAL METHADONE DOES NOT SIGNIFICANTLY INCREASE URINARY BLADDER SIZE IN UNANESTHETIZED RABBITS (1988) (1)
1583 – RECENT STUDIES ON OPIATE RECEPTORS (1978) (1)
Chloroacryloyl amides and alpha-methylenelactones from naltrexone, oxymorphone and fentanyl (1985) (1)
Studies using antibodies generated against peptide sequences from opioid binding protein and antibodies against rhodopsin (1990) (1)
Differential effects of cyanogen bromide on ligand binding by mu, delta and kappa opioid receptors. (1990) (1)
Opiate receptors and their implications for drug addiction. (1980) (1)
N-(3-Fluoropropyl)-N-normetazocine, a potentially useful opiate antagonist for opiate receptor studies with positron emission tomography (PET). (1985) (1)
Antinociception Following Subarachnoid Bestatin in Rats. (1994) (1)
Distribution of 3H-Morphine after Lumbar Epidural Administration in Unanesthetized Rabbits (1992) (1)
DIASTEREOMERIC 6-DESOXY-6-SPIRO-α-METHYLENE-Γ-BUTYROLACTONE DERIVATIVES OF NALTREXONE AND OXYMORPHONE. SELECTIVE IRREVERSIBLE INHIBITION OF NALTREXONE BINDING IN AN OPIOID RECEPTOR PREPARATION BY A CONFORMATIONALLY RESTRICTED MICHAEL (1985) (1)
Binding characteristics of μ and κ agonists in rat brain subcellular fractions (1982) (1)
DISTRIBUTION OF 3H MORPHINE FOLLOWING LUMBAR SUBARACHNOID ADMINISTRATION IN RABBITS (1987) (1)
CHARACTERIZATION OF SOLUBILIZED ACTIVE OPIATE RECEPTORS FROM TOAD BRAIN (1981) (1)
Recent Studies on Opioid Receptors (1988) (1)
Multiple opiate binding sites in human brain regions: evidence for kappa and sigma sites. (1982) (1)
Progress in the characterization of the opioid receptor subtypes: peptides as probes. Future directions. (1986) (1)
Recent Studies on a μ‐Opioid Receptor Purified from Bovine Striatum a (1995) (1)
A806 Low Dose Epidural Clonidine Enhances Morphine Analgesia Without Causing Hypotension in Rabbits (1990) (1)
Recent Studies on Opiate Receptors (1979) (1)
Selection of vehicle for epidural meperidine influences nociceptive latency in rabbits. (1990) (1)
1035 – KINETICS OF INACTIVATION OF OPIATE RECEPTORS BY SULFHYDRYL REAGENTS (1977) (0)
SUBARACHNOID DISODIUM EDTA INDUCES CONCENTRATION-DEPENDENT TETANIC CONTRACTION IN RATSPREVENTION BY CaCl2PRETREATMENT (1991) (0)
14. – OPIATE RECEPTORS: ISOLATION AND MECHANISMS (1977) (0)
[Opiate receptors and endorphins at the central nervous system level]. (1978) (0)
Book Review:Receptors for Neurotransmitters and Peptide Hormones. Giancarlo Pepeu, Michael J. Kuhar, S. J. Enna (1981) (0)
Recent studies on a mu-opioid receptor purified from bovine striatum. (1995) (0)
IS EDTA HARMLESS IN THE SUBARACHNOID SPACE (1989) (0)
Affinity crosslinking of 125I-human beta-endorphin to cell lines possessing either mu or delta type opioid binding sites. (1986) (0)
RECOVERY OF LIDOCAINE FOLLOWING INTERPLEURAL INJECTION IN RABBIT (1989) (0)
A1259 Subarachnoid EDTA Induces Hindlimb Myoclonus in Rats (1990) (0)
Developments in Opiate Research. Albert Herz (1979) (0)
Purification of Opioid Binding Proteins (1990) (0)
Epidural meperidine does not significantly increase urinary bladder size: a cystographic study in rabbits (1990) (0)
POTENTIAL AFFINITY LABELS FOR THE OPIATE RECEPTOR BASED ON FENTANYL AND RELATED COMPOUNDS (1983) (0)
The effects of chronic food restriction on mu and kappa opioid receptors in the rat (1994) (0)
Opioid receptors: molecular and structural studies. (1994) (0)
OPIOID AGONISTS AND ANTAGONISTS. 6-DESOXY-6-SUBSTITUTED LACTONE, EPOXIDE, AND GLYCIDATE ESTER DERIVATIVES OF NALTREXONE AND OXYMORPHONE (1985) (0)
A preliminary evaluation of analgesic latency of epidural analgesics in rabbits (1990) (0)
CONFORMATIONAL STATES OF THE OPIATE RECEPTOR (1978) (0)
Opiate Receptors and Their Ligands (1983) (0)
Affinity chromatography of morphine and related drugs. (1974) (0)
Recent studies on opioid receptors: heterogeneity and isolation (the Nathan B. Eddy Memorial Award lecture). (1984) (0)
Book Review:Endogenous Regulatory Peptides: Chemistry, Biology and Medical Significance. J. Menyhart (1990) (0)
SOLUBILIZATION AND CHARACTERIZATION OF ACTIVE OPIOID RECEPTORS BINDING SITES (1984) (0)
Polyamine metabolism in mouse neuroblastoma cell cultures. Abstr. (1973) (0)
Solubilization and Characterization of Active Opiate Binding Sites (1984) (0)
Binding characteristics of mu and kappa agonists in rat brain subcellular fractions. (1982) (0)
Studies on membrane-bound opiate receptors. (1979) (0)
Recent studies on a mu opioid binding protein purified from bovine striatal membranes. (1992) (0)
Erratum to: Identification of a neurorestrictive suppressor element (NRSE) in the human μ-opioid receptor gene (2002) (0)
Studies on mu-opioid-binding sites with peptide antibodies. (1992) (0)
Solubilization of κ-opioid receptors from guinea pig cerebellum (1984) (0)
Low dose clonidine enhances meperidine analgesia without hypotension following epidural administration in rabbits (1991) (0)
Opiate Receptors and Opioid Peptides: Are They Involved in Drug Addiction? (1984) (0)
Recent studies on heterogeneity and isolation of opioid receptors. (1987) (0)
Intravenous cystogram for study of urinary retention following intrathecal morphine in unanesthetized rabbits. (1988) (0)
Reconstitution in liposomes of a μ-opioid binding protein purified to homogeneity from bovine striatal membranes (1994) (0)
OPIOID RECEPTORS AND THEIR BIOCHEMISTRY (1992) (0)
Is EDTA innocuous in the subarachnoid space? (1989) (0)
DEVELOPMENT OF TOLERANCE TO OPIATES IN EXPLANTS OF MOUSE SPINAL CORD WITH ATTACHED DORSAL ROOT GANGLIA (1980) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Eric. J. Simon?

Eric. J. Simon is affiliated with the following schools:

New York University

Eric. J. Simon's Academic­Influence.com Rankings